Nickyv

[James Woods @RealJamesWoods]

Teddy Roosevelt’s dissertation on CNN written 100 years before its founding…

[d_stock @d_stock07734]

$NWBO
The August 6 MOU press release changes the status quo. Every party now has reason to move faster. They all understand how disruptive the DCVax platform could be, and nobody wants to be last to the table.

My read on why the MOU is non-binding: a binding agreement would trigger a filing requirement.

[Amanda Hollensbe (Braelyn’s Mom) @HollensbeAmanda]

Seeing how Braelyn’s own immune cells and tumor tissue were used to create her personalized DCVax-L vaccine was an experience I will never forget.

What was once just a treatment we had read about became something incredibly real when we met the scientists behind it.

Kristen has done such an amazing job bringing this experience to life through these videos. ❤️

Come inside Advent with us and see the science behind Braelyn’s vaccine!

And thank you, Kristen, for helping us share this extraordinary experience. ❤️

[Peter Davis @peter_brit]

#dcvax $nwbo #gbm

With the release of MHRA guidance on Real-World Evidence, the 'fuse has been lit' In the most recent $nwbo PR, DI ended with "We look forward to bringing you further updates" I do not recall him ever saying that before ? Perhaps a hint of more imminent news ?

[Peter Kostis @peterjkostis]

12 M shares and NWBO is up .009 this is laughable.

[SemperFITrader @SouthernDrive21]

$NWBO @MHRAgovuk @FDA @braintumourrsch @glioblastomaorg Clock is ticking for MHRA to pull the trigger on approval.

[d_stock @d_stock07734]

$NWBO

If the UK is moving to back DCVax-L at the national level, Linda Powers may not need to sell the 17-acre Sawston site after all. The company has retaind it since 2018 as a potential hub.

Cancer patients can benefit a lot from competitions!

[katsu @katsuxbt]

Nick Saban says he complained about how the media made him look like a bad guy until his wife asked if he’d ever watched his own press conferences

“I used to come home and complain about it. I would say, ‘I don’t understand why I’m being sort of depicted this way when that’s not really who I am.’ And she said, ‘Do you ever watch yourself?’”

“I said, ‘No.’ She said, Well, it comes from your press conferences. You know, you’re anxious. You don’t treat these people with much respect. You don’t have any relationships with them. You never smile…”

“You never joke. You never make people feel a part of what you’re trying to do or respect what they’re trying to do, which is to promote your sport. So, what do you expect?”

“And it really, really pissed me off that she said that because I didn’t realize that, but she was right.”

[Bio99 @BIO99_BIO99]

When the UK government is your partner to reach all cancers… will you be surprised when the UK government then approves it … for all cancers? $NWBO

[Beachhyena @RHINOBOY66]

For all those criminals who have been trying to destroy NWBO.
What say you to the following. It includes ALL SOLID TUMOURS not just GBM.

Quote from NHS site itself.

“NHSBlood and Transplant’s specialist therapeutic apheresis and cell processing capabilities [color=blue][/color]are supporting the production of DCVax®-L, with plans to expand the model to additional locations across England.

NHS Blood and Transplant’s Therapeutic Apheresis Services (TAS) and Cellular and Molecular Therapies (CMT) teams are supporting the UK production of DCVax®-L – a treatment for Glioblastoma multiforme (GBM), an aggressive form of primary brain cancer, as well as all solid tumours.”

https://t.co/dXdCtDmIUK

[Matthias Höppner @Mtzepeng]

$NWBO This week isn't just news. It's a narrative build-up.

MHRA — reformed framework that delivers
NHSBT — Advanced Therapies at national scale
NHS England — post-Brexit innovation leader

Every stakeholder has skin in this story.

Nobody builds this chain for a maybe.

[Michael Bigger @biggercapital]

Government Agencies and healthcare companies can’t use “Treatment” lightly. Unless I’m missing something ….. Please fill in the blank 😀 $NWBO

[Ron Greco @gr197667]

Reshare everyone knows someone with a solid tumor
$NWBO

[voloda @volodatrades]

The more I look at what $NWBO is doing, the more I think the strategy is becoming clear.
Imagine MHRA approval came first and THEN everyone asked:

“Where is the leukapheresis capacity?”
“Where will DCVax-L be manufactured?”
“How does the NHS pathway work?”
“Can you actually scale?”

Instead, NWBO appears to be building the infrastructure BEFORE the potential approval.

Sawston.
Leukapheresis.
NHSBT collaboration.
NHS oncology engagement.
Bosch presenting DCVax-L directly to the NHS community.

So when/if the MHRA approval arrives, the answer to those questions may already be:

Yes. We have it.

This is what commercialization readiness looks like.

The timing is VERY interesting. Go Linda

$NWBO #DCVax #GBM

[SemperFITrader @SouthernDrive21]

$NWBO Hard to believe they NHS would not know status of MHRA application for DCVAX

[One 00 /cent @eddieosnap]

Hi @amitisinvesting and @iamtomnash Check out a ticker I've been following and invested in for years: $NWBO. I know, I know... the share price has been disappointing. But don't stop at the chart. Do your own research on the company, its science, and recent developments before making up your mind. #DCVAX #GBM #Immunotherapy
https://t.co/dXPtjHPfbJ

[Tommy Bax 🇬🇧 🇹🇼 🇪🇺 @TomBaxers]

$NWBO PR Out:

Northwest Biotherapeutics and the UK National Health Service Blood and Transplant Announce Collaboration to Support DCVax-L Production https://t.co/NGbp9JmiqF

🔥

[RJM @rjmsoflo]

$NWBO #DCVaxForBraelyn

BEYOND BRAIN CANCER… THE NHS JUST PUT ALL SOLID TUMORS IN THE CONVERSATION. 🚀

Let this sink in.

The UK’s National Health Service Blood and Transplant is officially collaborating with Northwest Biotherapeutics and Advent Bioservices to support DCVax-L production, with plans to expand across England.

And the announcement describes DCVax-L as a treatment for glioblastoma “as well as all solid tumors.”

ALL SOLID TUMORS.

That is a profound statement about the potential of this personalized cancer immunotherapy platform.

We’re not just talking about one devastating disease. We’re talking about a technology being developed with the potential to address multiple forms of solid cancer.

And now the UK’s National Health Service Blood and Transplant is directly participating in DCVax-L production… collecting and processing patients’ immune cells, with plans to expand operations across England.

Think about what we’re witnessing…

A personalized cancer immunotherapy with remarkable long-term survivors… a Phase III trial reporting a survival benefit… and now the UK’s national blood and transplant service actively supporting production.

And let’s not overlook the timing… Dr. Marnix Bosch’s October 6 presentation, followed by this announcement of a formal NHS collaboration. Two significant developments within days of each other, while the MHRA decision remains pending.

Coincidence? Perhaps… but the pieces are falling into place. Manufacturing capabilities are being strengthened, national infrastructure is being aligned, and preparations for potential expansion are advancing.

To me, these are increasingly encouraging signs that approval is approaching.

More than two decades of research, clinical trials, and perseverance are converging at what could be a defining moment in cancer immunotherapy.

How is a story with this much potential still flying under the radar???

We’re talking about cancer patients and families fighting for more time… more birthdays… more memories… more life.

This story deserves to be heard far beyond the $NWBO investment community.

Be loud… be relentless… share, post, repost, and spread the word about $NWBO until your fingers bleed!

Cancer doesn’t take a day off… and neither should our voices.

$NWBO #DCVax #DCVaxL #DCVaxForBraelyn #Glioblastoma #GBM #BrainCancer #CancerResearch #CancerImmunotherapy #CancerVaccine #CancerTreatment #SolidTumors #MHRA #NHS #NorthwestBiotherapeutics #CancerAwareness

[kristen shaughnessy @kshaughnessy2]

$NWBO Interesting Week👀

Dr. Bosch’s keynote on how the tumor becomes the vaccine, followed by news of the NHS production step

Northwest and NHS Blood and Transplant will collect and process patient cells for DCVax-L, starting in Leeds and Oxford, with expansion planned across England.

That is a big deal because the NHS is building the production path days after Dr. Bosch’s keynote address followed the Cancer Vaccine Launch Pad talk, while UK approval is still pending.

@andrewcaravello @HollensbeAmanda @HollensbeBrae @gr197667 @smith348572 @ThomasOwenMcCa1 @LisainNJUSA